Valion Bio, Inc.: basic weighted-average shares
Basic weighted-average shares for Valion Bio, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Valion Bio, Inc. financial histories
What this measure means
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
Exact concept: us-gaap:WeightedAverageNumberOfSharesOutstandingBasic. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2021-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 1,155,531 | shares | 2026-03-30 | 10-K · 0001437749-26-010343 |
| 2024-01-01 | 2024-12-31 | 287,370 | shares | 2026-03-30 | 10-K · 0001437749-26-010343 |
| 2023-01-01 | 2023-12-31 | 46,650 | shares | 2025-03-21 | 10-K · 0000950170-25-043234 |
| 2022-01-01 | 2022-12-31 | 96,778 | shares | 2024-03-25 | 10-K · 0000950170-24-035946 |
| 2021-01-01 | 2021-12-31 | 3,493,267 | shares | 2023-03-31 | 10-K · 0000950170-23-011359 |
Related financial histories
- Valion Bio, Inc.: total assets
- Valion Bio, Inc.: total liabilities
- Valion Bio, Inc.: stockholders equity
- Valion Bio, Inc.: cash and cash equivalents
- Valion Bio, Inc.: net income or loss
- Valion Bio, Inc.: operating cash flow
- Valion Bio, Inc.: capital expenditure payments
- Valion Bio, Inc.: revenue
- Valion Bio, Inc.: financing cash flow
- Valion Bio, Inc.: investing cash flow
- Valion Bio, Inc.: retained earnings or deficit
- Valion Bio, Inc.: diluted weighted-average shares
- Valion Bio, Inc.: basic earnings per share
- Valion Bio, Inc.: diluted earnings per share
- Valion Bio, Inc.: net property, plant and equipment
- Valion Bio, Inc.: share-based compensation expense
- Valion Bio, Inc.: operating income or loss
- Valion Bio, Inc.: current assets
- Valion Bio, Inc.: current liabilities
- Valion Bio, Inc.: current accounts payable
- Valion Bio, Inc.: net current accounts receivable
- Valion Bio, Inc.: operating expenses
- Valion Bio, Inc.: net inventory
- Valion Bio, Inc.: gross profit
- Valion Bio, Inc.: cost of revenue
- Valion Bio, Inc.: research and development expense
Inspect the source
- Entity
- Valion Bio, Inc. / CIK 0001787740
- Captured
- 2026-09-21T17:31:36.532Z
- SEC response SHA-256
c71bc5adfd21131640f813d11643c96a18f367001a202e6e631ae3aec7d5d7c5
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001787740.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))